Date: August 17, 2015
Authors: Adrian F. Hernandez, MD, MHS, Director of Outcomes and Health Services Research, Duke Clinical Research Institute
Trust is central to the relationship between patients and their clinicians. It’s also essential to the relationship between patients and researchers if patients are to fully engage in clinical research.
The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved nearly $142.5 million to support the ongoing development and expansion of an ambitious new resource for health research known as PCORnet, the National Patient-Centered Clinical Research Network.
Date: July 21, 2015
Authors: Rachael Fleurence, PhD, Program Director, CER Methods and Infrastructure, PCORI and Joe Selby, MD, MPH, Executive Director, PCORI
When PCORI first proposed developing a national clinical research collaborative and community that would harness the power of partnerships and health data to improve patient outcomes, we knew we’d set out on an unprecedented and exciting path.
Review and provide comments on the ADAPTABLE study research protocol. ADAPTABLE is the first demonstration project to be conducted through PCORnet. ADAPTABLE is based on a model of sharing knowledge and provides a unique opportunity to engage and collaborate with physicians, patients, patient representatives, investigators, research study team members, and support staff.
Biosample Buzz; June 2015 As part of PCORnet, task forces were established to support and disseminate best practices. The goal of the Biorepository Task Force is to develop and foster systematic approaches that support a regulatory-compliant, comprehensive, and sustainable Network-wide approach to biorepositories to serve PCORnet research endeavors. The task force includes over 40 members, … Continue reading PCORnet focuses on improving capacity to conduct CER through research network
Precision Medicine Initiative (PMI) Working Group of the Advisory Committee to the NIH Director (ACD) Digital Health Data in a Million-Person Precision Medicine Initiative Cohort Thursday, May 28 – 8:30 a.m.-5:30 p.m. CT Friday, May 29 – 8:30 a.m.-12:30 p.m. CT Videocast: Precision Medicine Public Workshop The workshop will focus on solutions to challenges in … Continue reading Precision Medicine Initiative Public Workshop – May 28-29
Architecture-Specific Considerations and Methods for Data Quality Assessment in Collaborative Clinical Data Research Networks Presenter: Chunhua Weng, PhD Associate Professor, Department of Biomedical Informatics Columbia University, New York, NY Wednesday, May 27, 2015 2:00-3:00 p.m. ET Hosted by the PCORnet DSSNI Task Force Agenda: Introduction by Lesley Curtis, PhD, DSSNI Co-chair Topic: Architecture-Specific Considerations and … Continue reading Best Practice Session Sharing: Chunhua Weng, PhD – May 27
Clinician engagement in pragmatic research: From evolving roles and responsibilities to emerging opportunities for physicians and others! Presenter: Matthew Roe, MD Duke University Medical Center, Duke Clinical Research Institute Wednesday, May 20, 2015 1:00-2:00 p.m. ET Note: This topic is presented twice (May 20 and May 21) to accommodate the availability of audience members. Attendance … Continue reading Best Practice Session Sharing: Matthew Roe, MD – May 20
The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved a three-year, $14 million clinical trial designed to determine the best dose of aspirin to use to prevent heart attacks and strokes in people with heart disease.
The study, called ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-term Effectiveness), will compare the benefits and harms of a low- and regular-strength daily dose of aspirin in patients diagnosed with heart disease.
In his first blog post for US News and World Report, Seth Ginsberg, PI for the AR-PoWER PPRN, describes PCORnet as an emergent opportunity for patients to work more closely than ever before with researchers, leading to a much better understand of health conditions and outcomes.